Clinical Trial Update: Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/Phase 2 trial evaluating intrathecal trastuzumab for metastatic breast cancer patients with carcinomatous meningitis; the study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Carcinomatous Meningitis

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: Institut Curie | Conditions: Metastatic Breast Cancer, Carcinomatous Meningitis | Phase 1, Phase 2 | Status: COMPLETED